European Equities Traded in the US as American Depositary Edge Higher in Thursday Trading

European equities traded in the US as American depositary receipts were slightly higher late Thursday morning, edging 0.10% higher to 1,298.82 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by furniture maker Natuzzi (NTZ) and medical device maker EDAP TMS (EDAP), which climbed 18% and 7.3% respectively. They were followed by telecommunications company VEON (VEON) and biopharmaceutical company Genfit (GNFT), which were up 2.5% each.

The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which dropped 2.8% and 2.6% respectively. They were followed by accommodations booking company trivago (TRVG) and 3D printer company Materialise (MTLS), which were off 0.7% each.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Verona Pharma (VRNA), which increased 2.2% and 2% respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics (BCYC) and TC Biopharm (TCBP), which rose 1.8% and 1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and biotech firm Trinity Biotech (TRIB), which dropped 3.8% and 3% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which lost 1.6% and 1.5% respectively.